{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:07:01Z","timestamp":1774332421615,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"crossref","award":["VGHKS98-038"],"award-info":[{"award-number":["VGHKS98-038"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health Research Institute, Taiwan","award":["NHRI-CN-CL-98-PP10"],"award-info":[{"award-number":["NHRI-CN-CL-98-PP10"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jmii.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T08:50:31Z","timestamp":1414831831000},"page":"729-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country"],"prefix":"10.1016","volume":"49","author":[{"given":"Wei-Cheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsi-Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Len","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.08.010_bib1","series-title":"WHO global tuberculosis report 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jmii.2014.08.010_bib2","series-title":"Priority research questions for (TB HIV) in HIV-prevalent and resource limited settings","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jmii.2014.08.010_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.5588\/ijtld.10.0352","article-title":"A systematic review of risk factors for death in adults during and after tuberculosis treatment","volume":"15","author":"Waitt","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/980594","article-title":"Changing Concepts of \u201clatent tuberculosis infection\u201d in patients living with HIV infection","author":"Lawn","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jmii.2014.08.010_bib5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. Latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib7","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jmii.2014.08.010_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jech.54.1.64","article-title":"How does tuberculosis relate to HIV positive and HIV negative drug users?","volume":"54","author":"Keizer","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jmii.2014.08.010_bib9","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib10","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jmii.2014.08.010_bib11","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2014.08.010_bib13","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2014.08.010_bib14","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmii.2014.08.010_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2014.08.010_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1509.081336","article-title":"Tokyo-172 BCG vaccination complications, Taiwan","volume":"15","author":"Jou","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib18","series-title":"Centers for Disease for Disease Control 2013 annual report","author":"Centers for Disease Control, Department of Health, R.O.C. (Taiwan)","year":"2013"},{"key":"10.1016\/j.jmii.2014.08.010_bib19","series-title":"Taiwan tuberculosis control report 2012","author":"Centers for Disease Control, Department of Health, R.O.C. (Taiwan)","year":"2012"},{"key":"10.1016\/j.jmii.2014.08.010_bib20","unstructured":"Centers for Disease Control, Department of Health, R.O.C. (Taiwan). Taiwan government's responses to HIV\/AIDS. Taipei, Taiwan: Centers for Disease Control; Available at: http:\/\/www.cdc.gov.tw\/english\/page.aspx?treeid=e79c7a9e1e9b1cdf&nowtreeid=6bb9113c9e323e98 [accessed 01.10.13]."},{"key":"10.1016\/j.jmii.2014.08.010_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2014.08.010_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2307\/2529786","article-title":"An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.jmii.2014.08.010_bib23","article-title":"Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country","author":"Hung","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2014.08.010_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/1817-1737.58959","article-title":"Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV-positive individuals in Iran","volume":"5","author":"Mardani","year":"2010","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2334-10-348","article-title":"IFN-\u03b3 response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection","volume":"10","author":"Latorre","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1471-2334-13-513","article-title":"Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia","volume":"13","author":"Chkhartishvili","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JCM.42.2.829-831.2004","article-title":"Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods","volume":"42","author":"Sch\u00f6lvinck","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2014.08.010_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","article-title":"Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals","volume":"175","author":"Luetkemeyer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2014.08.010_bib29","first-page":"47","article-title":"Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program","volume":"4","author":"Salomon","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib30","first-page":"988","article-title":"Yield of tuberculin screening among injection drug users","volume":"8","author":"Brassard","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib31","first-page":"1183","article-title":"Tuberculosis infection in drug users: interferon-gamma release assay performance","volume":"11","author":"Grimes","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugpo.2013.10.002","article-title":"Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia","volume":"25","author":"R\u00fc\u00fctel","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jmii.2014.08.010_bib33","first-page":"310","article-title":"Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection","volume":"10","author":"Mahomed","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2014.08.010_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jinf.2012.11.004","article-title":"Tuberculosis skin test, but not interferon-\u03b3-releasing assays is affected by BCG vaccination in HIV patients","volume":"4","author":"Wolf","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2014.08.010_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2325957412469687","article-title":"The performance of QuantiFERON-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population","volume":"13","author":"James","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.jmii.2014.08.010_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/325295","article-title":"Performance of a whole-blood interferon-gamma release assay with Mycobacterium RD1-specific antigens among HIV-infected persons","volume":"2011","author":"Fujita","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jmii.2014.08.010_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1309\/LTETF72AHG94KGUY","article-title":"Evaluation of an in\u00a0vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test","volume":"125","author":"Taggart","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmii.2014.08.010_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.201107-1244OC","article-title":"Discordance among commercially available diagnostics for latent tuberculosis infection","volume":"185","author":"Mancuso","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:21:21Z","timestamp":1761657681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118214001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1684118214001790"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.08.010","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC","name":"copyright","label":"Copyright"}]}}